278 seed medtech investors
We list 278 seed medtech investors as of November 2026: 207 have an SEC filing on file and 71 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (61), New York (28) and Texas (17).
Top 5 seed medtech investors, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when seed is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
7wire Ventures
Type: VC firm · HQ: Chicago, IL · Stages: Seed · Focus: Medtech, Healthtech, AI, SaaS · Latest activity: New fund, Oct 2026 · Fund size on file: $300M (SEC Form D, 2022)
Latest fund filing dated Oct 2026; $300M fund on file (SEC Form D, 2022); 76% of its observed portfolio is medtech and medical devices; backs seed; 8 named decision-makers on file.
HealthX Ventures
Type: VC firm · HQ: Madison, WI · Stages: Seed · Focus: Medtech, Healthtech, AI, SaaS · Latest activity: New deal, Sep 2026 · Fund size on file: $100M (SEC Form D, 2023)
Dated new deal in Sep 2026; $100M fund on file (SEC Form D, 2023); 50% of its observed portfolio is medtech and medical devices; backs seed; 8 named decision-makers on file.
Mercia Asset Management
Type: Fund manager · HQ: Henley-in-Arden, United Kingdom · Stages: Seed, Series A, Growth · Focus: Medtech, Healthtech, Future of Work, AI · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: £400M (own site)
Portfolio news dated Oct 2026; £400M on file (own site); 100% of its observed portfolio is medtech and medical devices; backs seed, Series A, growth-stage; 8 named decision-makers on file.
SHD Partners
Type: VC firm · HQ: Dallas, TX · Stages: Seed, Series A · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Nov 2026 · Private fund assets: $61M (SEC Form ADV)
Portfolio news dated Nov 2026; $61M on file (SEC Form ADV); 53% of its observed portfolio is medtech and medical devices; backs seed, Series A; 6 named decision-makers on file.
Digitalis Ventures
Type: VC firm · HQ: New York, NY · Stages: Seed · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Nov 2026 · Private fund assets: $862M (SEC Form ADV)
Portfolio news dated Nov 2026; $862M on file (SEC Form ADV); states medtech and medical devices as a focus; backs seed; 8 named decision-makers on file.
First 25 of 278 seed medtech investors
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| 7wire Ventures | VC firm | Chicago, IL | Seed | Medtech, Healthtech, AI, SaaS | New fund, Oct 2026 | $300M (SEC Form D, 2022) | 4 Nov 2026 | 8 names · Unlock |
| HealthX Ventures | VC firm | Madison, WI | Seed | Medtech, Healthtech, AI, SaaS | New deal, Sep 2026 | $100M (SEC Form D, 2023) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Mercia Asset Management | Fund manager | Henley-in-Arden, United Kingdom | Seed, Series A, Growth | Medtech, Healthtech, Future of Work, AI | Portfolio news, Oct 2026 | £400M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 5 Nov 2026 | 6 names, firm email · Unlock |
| Digitalis Ventures | VC firm | New York, NY | Seed | Medtech, Healthtech, Biotech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 5 Nov 2026 | 8 names, firm email · Unlock |
| HC9 Ventures | VC firm | Havertown, PA | Seed, Series A | Medtech, Healthtech, AI, Fintech | New fund, Oct 2026 | $85M (SEC Form D, 2025) | 4 Nov 2026 | 3 names · Unlock |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | €425M (own site) | 7 Nov 2026 | 2 names, firm email · Unlock |
| Gore Range Capital | VC firm | Southlake, TX | Seed | Medtech, Healthtech, Biotech | New deal, Aug 2026 | $250M (SEC Form D, 2026) | 4 Nov 2026 | 1 name, firm email · Unlock |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, Edtech, Developer Tools | Portfolio news, Oct 2026 | £3.0B (own site) | 4 Nov 2026 | 8 names · Unlock |
| 25Madison Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A | Medtech, Healthtech, AI, Logistics | New fund, Oct 2026 | $50M (SEC Form D, 2026) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Cambridge Angels | Angel network | Cambridge, United Kingdom | Seed | Medtech, Healthtech, Biotech, Deep Tech | Portfolio news, Oct 2026 | £400M (own site) | 4 Nov 2026 | LinkedIn page · Unlock |
| Heinz Ventures, LLC | VC firm | Memphis, TN | Pre-seed, Seed | Medtech, Healthtech | New deal, Aug 2026 | $10M (SEC Form D, 2024) | 4 Nov 2026 | 5 names, firm email · Unlock |
| Hatteras Venture Partners | VC firm | Durham, NC | Seed | Medtech, Healthtech, Biotech | New fund, Oct 2026 | $250M (SEC Form D, 2023) | 4 Nov 2026 | 8 names · Unlock |
| Safar Partners | VC firm | Cambridge, MA | Seed | Medtech, Healthtech, Industrial Tech, Biotech | New deal, Aug 2026 | $300M (SEC Form D, 2023) | 4 Nov 2026 | 3 names, firm email · Unlock |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Media | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 5 Nov 2026 | 8 names · Unlock |
| Coyote Ventures | VC firm | San Francisco, CA | Seed | Medtech, Healthtech, Fintech, Impact | Portfolio news, Aug 2026 | $2M (SEC Form D, 2021) | 5 Nov 2026 | 8 names · Unlock |
| RPM Ventures | VC firm | Ann Arbor, MI | Seed | Medtech, Space, Future of Work, Healthtech | New fund, Sep 2026 | $165M (SEC Form D, 2026) | 4 Nov 2026 | 3 names · Unlock |
| Inspired | VC firm | New York, NY | Seed | Medtech, AI, Fintech, Generalist | New fund, Oct 2026 | $450M (SEC Form D, 2026) | 4 Nov 2026 | 8 names · Unlock |
| Parkwalk Advisors | SEIS/EIS fund | London, United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Industrial Tech | New fund, Sep 2026 | £500M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Reveille | VC firm | New York, NY | Seed | Medtech, Defense Tech, Energy, Space | New fund, Nov 2026 | $40M (SEC Form D, 2025) | 4 Nov 2026 | 3 names, firm email · Unlock |
| NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Medtech, Healthtech, Biotech | New fund, Sep 2026 | €300M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Angelor | VC firm | Lyon, France | Seed, Series A | Medtech, Healthtech, Biotech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 7 Nov 2026 | 1 name · Unlock |
| Grand Ventures | VC firm | Grand Rapids, MI | Seed | Medtech, AI, Developer Tools, Fintech | New deal, Sep 2026 | $100M (SEC Form D, 2022) | 5 Nov 2026 | 6 names, firm email · Unlock |
| Blu Ventures | VC firm | Arlington, VA | Seed | Medtech, Healthtech, Cybersecurity, AI | New fund, Jun 2026 | $215M (SEC Form ADV) | 5 Nov 2026 | 5 names · Unlock |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Medtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
You are seeing 25 of 278. The full list adds 253 more investors and 1,351 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 278 break down
By region
| Region | On this list | Share |
|---|---|---|
| United States | 205 | 74% |
| United Kingdom | 45 | 16% |
| Europe | 28 | 10% |
By US state
| US state | On this list | Share |
|---|---|---|
| California | 61 | 22% |
| New York | 28 | 10% |
| Texas | 17 | 6% |
| Massachusetts | 14 | 5% |
| Illinois | 8 | 3% |
| Pennsylvania | 7 | 3% |
| Tennessee | 7 | 3% |
| Florida | 7 | 3% |
| Washington | 5 | 2% |
| Wisconsin | 4 | 1% |
By European country
| European country | On this list | Share |
|---|---|---|
| Netherlands | 7 | 3% |
| France | 6 | 2% |
| Norway | 2 | 1% |
| Spain | 2 | 1% |
| Italy | 2 | 1% |
| Czech Republic | 2 | 1% |
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 248 | 89% |
| Angel network | 10 | 4% |
| SEIS/EIS fund | 7 | 3% |
| Fund manager | 6 | 2% |
| Government or university fund | 4 | 1% |
| Corporate VC | 2 | 1% |
Method and limits
- Source
- 207 of the 278 rows carry an SEC filing (Form D or Form ADV). All 278 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at seed.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when seed is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 9 Nov 2026.
- Fill rates
- Of 278 rows: stage 278, sector 278, fund size 215, website 278. In the paid file: named decision-makers on 265 rows, firm email on 119, LinkedIn page on 173, check size on 53.
- Corrections
- Email [email protected] or use the update form. We act within 5 working days.
Questions
How many seed medtech investors are there?
We list 278 as of November 2026. 132 of the 278 have a fund filing or a dated deal in the last 12 months.
Which seed medtech investors raised a new fund in the last 12 months?
71 of the 278 have a fund filing dated in the last 12 months. The most recent on this list are Reveille (Nov 2026), 25Madison Ventures (Oct 2026) and Inspired (Oct 2026).
What is the typical fund size of seed medtech investors?
The median fund size on file for this list is $50M, across the 148 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 130 do not disclose a size there.
How do I contact seed medtech investors?
The paid file holds 1,351 named decision-makers across 265 of these 278 and a firm email for 119. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on seed medtech investors come from?
207 of the 278 rows have an SEC filing on file (Form D or Form ADV) and 71 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.
Broader lists
Narrower lists
Related lists
Seed AI investors (1,082)Seed SaaS investors (1,010)Seed healthtech investors (800)Seed fintech investors (584)Seed deep tech investors (555)Seed climate tech investors (458)Seed consumer investors (331)Seed B2B investors (302)Seed biotech investors (300)Seed energy investors (261)Seed industrial tech investors (249)Seed hardware investors (225)Seed cybersecurity investors (205)Seed robotics investors (153)Seed developer tools investors (140)Pre-seed medtech investors (129)Series A medtech investors (125)Seed media investors (125)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to medtech and medical devices and seed. Guide: how many investors to pitch. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.